Showing results (101-110 of 142) with videos related to
Sort By:
Pageof 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1992
Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinumL Kostakoglu, S D Yeh, C Portlock, et al.Anaesthesia|July 22, 2010
Optimal timing for the administration of intranasal dexmedetomidine for premedication in childrenV M Yuen, Theresa W Hui, M G Irwin, et al.The Oncologist|September 3, 2011
The significance of early alpha-fetoprotein level changes in predicting clinical and survival benefits in advanced hepatocellular carcinoma patients receiving sorafenibThomas Yau, T J Yao, Pierre Chan, et al.Vaccine|November 1, 1994
Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanomaP O Livingston, S Adluri, F Helling, et al.Leukemia|January 1, 1996
Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemiaP G Maslak, M A Weiss, E Berman, et al.Environmental Science & Technology|February 10, 2015
Assessment of regional variation in streamflow responses to urbanization and the persistence of physiographyKristina G Hopkins, Nathaniel B Morse, Daniel J Bain, et al.Cancer|October 15, 1994
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancerD P Kelsen, L Saltz, A M Cohen, et al.Investigational New Drugs|March 10, 2012
Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory diseaseThomas Yau, Hilda Wong, Pierre Chan, et al.Cancer Research|December 1, 1994
Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trialD Fennelly, C Wasserheit, J Schneider, et al.Cancer|February 15, 1993
Phase II trial of carboplatin and etoposide in metastatic breast cancerJ Crown, T Hakes, B Reichman, et al.Pageof 15